What changed
$LRCX — AVOID 📊 | 6 MONTHS THESIS
🎯 Q1 2026 | Rev $5.8B | EPS $1.47 vs $1.36 🟢 | Margin 35.0%
💡 Consensus expects AI-driven capital spending to sustain hypergrowth, but at 76.6x earnings the market has already discounted many years of elevated demand. My variant view is that even a modest growth deceleration or sector rotation will trigger PE compression, limiting upside to ~11% while downside to historical valuation norms is -11%, leaving...
📉 Reward/risk: 1.02:1
🏢 Business Quality: 9/10 - LRCX holds near-monopoly positions in etch and deposition, critical for advanced chipmaking, with deep technological moats and high switching costs.
📊 Valuation: rich — PE 76.6x vs historical median 14.5x and prior peak 34.3x; EV/EBITDA likely >50x; FCF yield depressed.
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/LRCX0624